RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.840
-0.030 (-3.46%)
At close: Apr 28, 2026, 4:00 PM EDT
0.845
+0.005 (0.60%)
After-hours: Apr 28, 2026, 4:04 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $37.84 million as of April 28, 2026. Its market cap has increased by 30.91% in one year.
Market Cap
37.84M
Enterprise Value
32.39M
1-Year Change
30.91%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $37.84M, a decrease of -44.87%. That is a compound annual growth rate of -11.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 39.20M | 27.32% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensei Biotherapeutics | 42.27M |
| Rein Therapeutics | 41.78M |
| Plus Therapeutics | 41.10M |
| Atara Biotherapeutics | 40.81M |
| Palatin Technologies | 40.76M |
| Werewolf Therapeutics | 40.34M |
| Aligos Therapeutics | 39.79M |
| INmune Bio | 39.08M |